WP Advisors LLC Decreases Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

WP Advisors LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 17.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,544 shares of the exchange traded fund’s stock after selling 2,927 shares during the quarter. WP Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,256,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the business. Avoro Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth about $396,844,000. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after acquiring an additional 730,000 shares during the last quarter. Jane Street Group LLC increased its holdings in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after acquiring an additional 391,333 shares during the last quarter. Baymount Management LP purchased a new stake in SPDR S&P Biotech ETF in the 1st quarter worth about $34,160,000. Finally, Blackstone Inc. increased its holdings in SPDR S&P Biotech ETF by 674.8% in the 4th quarter. Blackstone Inc. now owns 337,030 shares of the exchange traded fund’s stock worth $30,093,000 after acquiring an additional 293,530 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 0.3 %

XBI traded up $0.35 during trading hours on Friday, hitting $101.26. The stock had a trading volume of 5,282,148 shares, compared to its average volume of 9,933,803. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The company’s fifty day simple moving average is $97.17 and its 200 day simple moving average is $93.57. The stock has a market cap of $7.72 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.